Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis

作者
Anthony Yu,Alexandra Ritenour,Jennifer Vincent,Chanhyun Park,Karen L. Rascati,Paul J. Godley
出处
期刊:Postgraduate Medicine [Taylor & Francis]
卷期号:136 (1): 14-21
标识
DOI:10.1080/00325481.2023.2288560
摘要

OBJECTIVES: To describe the clinical profile of nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) patients in a Texas integrated delivery network (IDN) and elucidate the local relationship between patient factors and the risk of advanced fibrosis. METHODS: This observational, retrospective, cross-sectional study utilized existing data from the electronic health record at a large Texas IDN. Data was collected during the study period from 1 January 2019, to 1 March 2023. Patient characteristics, comorbidities, labs, and medication orders were collected from the most recent encounter in which a Fibrosis-4 (FIB-4) score could be calculated. Chi square tests and analysis of variance (ANOVA) tests were conducted to evaluate differences among the three fibrosis risk categories. Ordinal logistic regression was utilized to assess associations between select variables and a higher risk of advanced fibrosis. RESULTS: A total of 56,253 patients were included in the study. 34,839 (61.9%) were Low-Risk 15,578 (27.7%) were Intermediate-Risk, and 5,836 (10.4%) were High-Risk of advanced fibrosis. Results showed that up to 70.4% of patients within a risk group were obese. Only 49.5% of patients in the High-Risk group had at least one gastroenterologist or hepatologist visit. Males, Medicare patients, former smokers, and those with hypertension, type 2 diabetes, and chronic kidney disease were associated with a higher risk of advanced fibrosis. CONCLUSION: This study highlights the need for early screening and proactive management of metabolic risk factors for patients with NAFLD/NASH. The findings indicate a notable prevalence of obesity in the study population, a need for specialist referral for those at High-Risk of advanced fibrosis, and the importance of routine labs to evaluate metabolic factors. Primary care providers may be ideal providers to target these interventions and address this care need.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hy1234完成签到 ,获得积分10
刚刚
linnya发布了新的文献求助10
1秒前
bylee发布了新的文献求助10
1秒前
LLL发布了新的文献求助10
3秒前
3秒前
9秒前
十一发布了新的文献求助10
10秒前
高贵三颜发布了新的文献求助30
11秒前
会撒娇的半鬼完成签到,获得积分20
11秒前
sang发布了新的文献求助10
11秒前
11秒前
黎明发布了新的文献求助10
11秒前
清脆海雪完成签到 ,获得积分10
12秒前
漂亮焦关注了科研通微信公众号
13秒前
蓝色牛马发布了新的文献求助10
13秒前
14秒前
科研通AI6.4应助kb采纳,获得10
15秒前
jinjinjin发布了新的文献求助10
15秒前
ember6发布了新的文献求助10
16秒前
Lucas应助落后雁菱采纳,获得10
16秒前
16秒前
bububusbu发布了新的文献求助10
17秒前
不良人完成签到,获得积分10
17秒前
SciGPT应助梨花采纳,获得10
19秒前
多情嫣然发布了新的文献求助10
19秒前
无花果应助咿呀呀采纳,获得10
19秒前
星野发布了新的文献求助30
20秒前
迅速初柳发布了新的文献求助10
21秒前
orixero应助zgm采纳,获得10
21秒前
22秒前
明理雨莲完成签到 ,获得积分10
22秒前
AN完成签到,获得积分0
22秒前
23秒前
王彦霖发布了新的文献求助10
23秒前
Orange应助14采纳,获得10
24秒前
小曾发布了新的文献求助10
25秒前
bububusbu完成签到,获得积分10
26秒前
惊蛰完成签到,获得积分10
26秒前
Panda_Zhou发布了新的文献求助10
27秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7321644
求助须知:如何正确求助?哪些是违规求助? 8937197
关于积分的说明 18947645
捐赠科研通 6979712
什么是DOI,文献DOI怎么找? 3214798
关于科研通互助平台的介绍 2382425
邀请新用户注册赠送积分活动 2194074